GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Other Current Liabilities

Aptorum Group (Aptorum Group) Other Current Liabilities : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Other Current Liabilities?

Aptorum Group's other current liabilities for the quarter that ended in Jun. 2023 was $0.00 Mil.

Aptorum Group's quarterly other current liabilities declined from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Jun. 2023 ($0.00 Mil).

Aptorum Group's annual other current liabilities declined from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) and declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil).


Aptorum Group Other Current Liabilities Historical Data

The historical data trend for Aptorum Group's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Other Current Liabilities Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial - - - - -

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aptorum Group Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Aptorum Group Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines